The effects of drugs were evaluated in 47 cases with variant angina (VA), 19 with resting angina showing ST depression (RA), and 84 with unstable angina (UA). In VA patients, calcium antagonists were effective in 87.1 % of the cases, while other drugs were effective in 56.3%. The difference was statistically significant. In RA patients, calcium antagonists were effective in 80.0% of the cases and other drugs in 44.4%. Nifedipine was effective in all 5 cases of VA without marked coronary stenosis, and in 83.7% of VA cases with coronary stenosis of more than 75.0%. All cases of RA had multiple vessel disease and nifedipine was effective in 80.0% of the patients. Nifedipine was effective in 83.3% of VA cases showing ST elevation during an exercise test, and was particularly effective in all patients having attacks only at rest. The effects of nifedipine were confirmed in 83.8% of UA cases. These results indicate that calcium antagonists are effective in VA, RA, and UA.
included in Group 1. Ninety patients were diagnosed as suffering from RTUA, and 24 of these cases were included in Group 2.
Cinecoronary arteriography was performed in 42 of the Group 3 patients. One patient from Group 3a (VTUA) and 1 from Group 3b (RTUA) had no attacks during their terms of admission and were discharged without medication. Myocardial infarction developed in 1 case of each type immediately after admission, while another patient (VTUA) had emergency A-C bypass surgery before drug administration. Therefore, of the 42 Group 3 patients in whom cinecoronary arteriography was performed, 37 (16 with VTUA and 21 with RTUA) received medical treatment.
Patients with a history of myocardial infarction were excluded from all groups.
2. Cinecoronary arteriography Coronary arteriography was carried out using Judkins' technique. The findings were classified into 2 groups. Cases with at least a 75% constriction of the luminal diameter were defined as having significant coronary artery stenosis, while those with narrowing of less than 75% were categorized as being without marked organic stenosis.
Drugs
The following daily dosages were used: nifedipine ranged from 30 to 60 mg (usually 40mg), diltiazem from 90 to 180 mg (usually 120mg) , verapamil from 120 to 240mg (usually 160mg), perhexiline from 300 to 400mg (usually 300mg), molsidomine 6mg, propranolol from 30 to 90mg (usually 40mg) , nicorandil from 20 to 30mg (usually 20mg), and isosorbide from 30 to 40mg (usually 40mg). Nifedipine was mainly used in the present study. Molsidomine7) and nicorandil8) are new antianginal agents recently developed in Japan, although their pharmacological mode of action on angina pectoris is not yet known.
Effectiveness of the drugs
The effects of the drugs were evaluated and ranked as follows: markedly effective-complete elimination of anginal attacks within 3 days; effective -complete elimination of attacks after 3 days or a reduction in the number of attacks by at least 50% during the periods of drugs administration; ineffective-reduction of the number of attacks by less than 50% during the periods of drug administration.
Jpn. Heart J. N ovember 1982 RESULTS Table I shows the effects of the drugs on variant angina and resting angina. Nifedipine was used in most patients, and the effects were obtained in 88.0% of the patients with variant angina and in 66.7% of those with resting angina. All the calcium antagonists, including nifedipine, displayed beneficial effects in 87.1 % of the patients with variant angina and in 80% with resting angina. The lower row of Table I shows the effects of drugs other than calcium antagonists. The drugs used include isosorbide, propranolol, molsidomine, nicorandil, and anticoagulants. Beneficial effects were obtained in 56.3% of 
Effects of the drugs on variant angina and resting angina

Unstable angina
In order to study the effects of calcium antagonists on unstable angina, the effectiveness of medical treatments employed prior to the clinical introduction of nifedipine was compared with the effectiveness of calcium antagonists. Because the definition of unstable angina has only been established recently, it was diagnosed in only 16 patients before 1968 (Table IV) , and the drugs were found to be effective in 62.5% of these cases. Prenylamine was the only calcium antagonist used during this period and was found to be effective in 2 out of the 3 patients treated. Myocardial infarction developed in the remaining patients. Of the 13 patients who were treated with other drugs, isosorbide and propranolol were effective in all patients in the respective samples (2 and 5 respectively). By contrast, anticoagulants were effective in only 1 out of 4 patients and dipyridamol was ineffective in 2 patients.
Since the introduction of nifedipine in 1968, beneficial effects of pharmacological treatment of unstable angina were reported in 49 of 68 cases (72.1%). The agents used are shown in Table V . Nifedipine was the main calcium antagonist used and its efficacy rate was 83.8% (31 of 37 patients). Drugs other than calcium antagonists included isosorbide, propranolol, and anticoagulants. Their effectiveness was 63.2% (12 out of 19 patients). The incidence of development into acute myocardial infarction was 25.0% before 1968 and 17.6% afterwards. Although no statistical significance was demonstrated, the beneficial effects of the drugs seemed to increase and the rate of incidence of development into acute myocardial infarction to decrease after 1968. Jpn. Heart J. November 1982
DISCUSSION
Our first trials on the use of nifedipine started around 1966 and its effectiveness in patients with angina pectoris of effort was confirmed by sequential analysis according to the method of Armitage.9) Next, we used this drug in patients with variant angina for trials, obtaining effects in 9 out of 10 patients.10) These results suggested that nifedipine and other calcium antagonists might be effective not only in variant angina, but also in resting angina and unstable angina. Double-blind tests are usually required to evaluate the effectiveness of a drug. In cases of variant angina, Parodi et a14) described the effectiveness of verapamil by comparing it with an inactive placebo by the crossover method, using continuous electrocardiographic recording. Rosenthal et al5) carried out a randomized double-blind crossover trial to compare the effects of diltiazem and an inactive placebo, obtaining a higher efficacy rate for diltiazem in variant angina. However, several problems are involved in employing double-blind tests in patients with variant angina, because of the risk of occurrence of serious arrhythmias and development into acute myocardial infarction. In some cases, there is a danger of sudden death occurring. For this reason, we did not undertake a double-blind test.
From this viewpoint, we made a survey of the effectiveness of calcium antagonists on variant angina in a large number of patients.11) The results obtained from 11 cardiology institutes in Japan showed the efficacy rates of nifedipine, diltiazem, and verapamil to be 94.0%, 90.8%, and 85.7%, respectively. As reported in this paper, the results obtained in the authors' institution revealed that calcium antagonists were significantly more effective than other drugs. It must be noted that nifedipine was markedly effective in all patients without marked narrowing of coronary arteries, while it was less effective in patients with multiple-vessel disease.
On the basis of the findings of coronary arteriography and provocation tests using ergonovine maleate,12) the pathogenesis of variant angina is generally ascribed to a coronary spasm. Therefore, there appears to be little doubt that the marked effectiveness of calcium antagonists on variant angina can be ascribed to their antispasmodic action. However, since in our studies, the efficacy rate decreased as the number of the diseased coronary arteries increased, it is possible that organic coronary stenosis may also be related to the genesis of variant angina.
The present study demonstrated that calcium antagonists are effective on resting angina. It is of interest that all 5 patients with resting angina, in whom coronary arteriography was performed, had multiple-vessel disease. The genesis of resting angina is not clear, but the belief that a coronary spasm may play an important role is finding growing acceptance. According to Yasue et al13) and Maseri et al, 14) ST depression appears when the blood perfuses the distal part of the coronary artery, at the site of a coronary spasm, through the collaterals. In other words, angina pectoris with ST elevation is produced by transmural myocardial ischemia when coronary spasm occurs, but in cases having numerous collaterals, the myocardial ischemia does not reach the epicardium, producing angina pectoris showing ST depression.
This explanation is consistent with our findings that all patients with resting angina had multiple-vessel disease, because, in such patients, collaterals may be well developed. However, cases of variant angina without organic stenosis may lack the development of collaterals. One must also consider the possibility that the difference between ST elevation and depression may depend on the intensity or extent of the coronary spasm, without relationship to the collaterals.13)-15) In addition, the fact that the effects of nifedipine on resting angina were similar to those on variant angina with multiple-vessel disease suggests that the genesis of resting angina like variant angina with multiple-vessel disease, is due to a spasm.
On the other hand, it has been reported that nifedipine is effective in patients with ordinary exertional angina.16),17) The action of the antianginal agents in exertional angina is generally explained by either coronary vasodilation or suppression of the myocardial oxygen consumption. In this connection, it is noticeable that some patients with variant angina show ST elevation even during an exercise test. Yasue et al18) and Specchia et al19) described how a coronary spasm with ST elevation was demonstrated in such cases during exertional angina provoked by an ergometer test, and suggested that the genesis of ST elevation can be explained by coronary spasms. However, it is premature to state that coronary spasms play a major role in all patients with exertional angina. More evidence is needed to reject the current belief that most of the action of calcium antagonists on exertional angina can be ascribed to either coronary vasodilation or the suppression of myocardial oxygen consumption.
It is interesting that the calcium antagonists are effective in all patients with ST elevation occurring only at rest, while the efficacy rates of the drugs were a little lower in patients with ST elevation during an exercise test.
There are 2 types of unstable angina: the variant type (VTUA) and the resting type (RTUA). The fact that the incidence of development of myocardial infarction in cases of unstable angina decreased after the introduction of nifedipine can be seen from its effectiveness on both VTUA and RTUA . Moses et al20) and Previtali et al21) also reported that nifedipine alone or a Jpn. Heart J. November 1982 combination of nifedipine, propranolol, and isosorbide abolished or reduced the frequency of attacks in unstable angina.
According to recently published papers, the aggregation of platelets plays an important role in the development of unstable angina into myocardial infarction.22)-24) Therefore, the relationship between the calcium antagonists and the role played by the platelet aggregation must also be taken into account. Maseri et al25) described that intracoronary injections of large doses of isosorbide within 45min after the onset of acute myocardial ischemia failed to open the occluded vessel, while Ganz et al26) reported that intracoronary thrombolysin (a mixture of streptokinase and plasmin) restored the coronary flow in 19 out of 20 patients who were hospitalized within 3 hours of the onset of their attacks.
These reports suggest that the attacks are initiated by a coronary spasm and that acute myocardial infarction develops as the result of thrombotic obstructions of the coronary arteries due to platelet aggregation. If so, a strong emphasis should be placed on the possibility that the effects of calcium antagonists on coronary spasms may prevent development of acute myocardial infarction.
